{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:22:08Z","timestamp":1787030528805,"version":"build-2736575974"},"reference-count":58,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2018.6769","type":"journal-article","created":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T03:54:04Z","timestamp":1537329244000},"source":"Crossref","is-referenced-by-count":7,"title":["Stem cell transplantation for the treatment of patients with type\ufffd1 diabetes mellitus: A meta\u2011analysis"],"prefix":"10.3892","author":[{"given":"Jiadi","family":"Gan","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2018,9,19]]},"reference":[{"key":"key20200713115203_b1-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.diabres.2009.10.007","article-title":"Global estimates of the prevalence of diabetes for 2010 and 2030","volume":"87","author":"Shaw","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"key20200713115203_b2-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/S0140-6736(11)61351-2","article-title":"Breast and cervical cancer in 187 countries between 1980 and 2010: A systematic analysis","volume":"378","author":"Forouzanfar","year":"2011","journal-title":"Lancet"},{"key":"key20200713115203_b3-etm-0-0-6769","first-page":"pii","article-title":"Anti-diabetics and chronic kidney disease","volume":"32","author":"Garofalo","year":"2015","journal-title":"G Ital Nefrol"},{"key":"key20200713115203_b4-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3341\/kjo.2014.28.5.373","article-title":"Diabetic retinopathy risk factors: Plasma erythropoietin as a risk factor for proliferative diabetic retinopathy","volume":"28","author":"Gholamhossein","year":"2014","journal-title":"Korean J Ophthalmol"},{"key":"key20200713115203_b5-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/nature08933","article-title":"Genetics, pathogenesis and clinical interventions in type 1 diabetes","volume":"464","author":"Bluestone","year":"2010","journal-title":"Nature"},{"key":"key20200713115203_b6-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"779","DOI":"10.2337\/diabetes.38.6.779","article-title":"Double-blind controlled trial of azathioprine in children with newly diagnosed type I diabetes","volume":"38","author":"Cook","year":"1989","journal-title":"Diabetes"},{"key":"key20200713115203_b7-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.diabres.2013.03.003","article-title":"Decline of C-peptide during the first year after diagnosis of Type 1 diabetes in children and adolescents","volume":"100","author":"Ludvigsson","year":"2013","journal-title":"Diabetes Res Clin Pract"},{"key":"key20200713115203_b8-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1056\/NEJMoa0904452","article-title":"Rituximab, B-lymphocyte depletion and preservation of beta-cell function","volume":"361","author":"Pescovitz","year":"2009","journal-title":"N Engl J Med"},{"key":"key20200713115203_b9-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"3901","DOI":"10.2337\/db13-0236","article-title":"Teplizumab preserves C-peptide in recent-onset type 1 diabetes: Two-year results from the randomized, placebo-controlled Prot\u00e9g\u00e9 trial","volume":"62","author":"Hagopian","year":"2013","journal-title":"Diabetes"},{"key":"key20200713115203_b10-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.immuni.2010.04.002","article-title":"Immunotherapy of type 1 diabetes: Where are we at and where should we be going","volume":"32","author":"Luo","year":"2010","journal-title":"Immunity"},{"key":"key20200713115203_b11-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1111\/j.1600-6143.2010.03073.x","article-title":"Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab","volume":"10","author":"Posselt","year":"2010","journal-title":"Am J Transplant"},{"key":"key20200713115203_b12-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJM200007273430401","article-title":"Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen","volume":"343","author":"Shapiro","year":"2000","journal-title":"N Engl J Med"},{"key":"key20200713115203_b13-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"a007823","DOI":"10.1101\/cshperspect.a007823","article-title":"Update on islet transplantation","volume":"2","author":"McCall","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"key20200713115203_b14-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.transproceed.2012.02.028","article-title":"Synergistic effect of surface modification with Poly(ethylene glycol) and immunosuppressants on repetitive pancreatic islet transplantation into antecedently sensitized rat","volume":"45","author":"Jeong","year":"2013","journal-title":"Transplant Proc"},{"key":"key20200713115203_b15-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.2337\/db06-0484","article-title":"In vivo imaging of immune rejection in transplanted pancreatic islets","volume":"55","author":"Evgenov","year":"2006","journal-title":"Diabetes"},{"key":"key20200713115203_b16-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1097\/00007890-199604270-00027","article-title":"Evidence of recurrent autoimmunity in human allogeneic islet transplantation","volume":"61","author":"Stegall","year":"1996","journal-title":"Transplantation"},{"key":"key20200713115203_b17-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s12026-013-8450-7","article-title":"The allure and peril of hematopoietic stem cell transplantation: Overcoming immune challenges to improve success","volume":"57","author":"Newman","year":"2013","journal-title":"Immunol Res"},{"key":"key20200713115203_b18-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"328","DOI":"10.5966\/sctm.2012-0116","article-title":"Stem cell therapy to cure type 1 diabetes: From hype to hope","volume":"2","author":"Chhabra","year":"2013","journal-title":"Stem Cells Transl Med"},{"key":"key20200713115203_b19-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"166","DOI":"10.2174\/1574888X09666141112114011","article-title":"Clinical outcomes of the transplantation of stem cells from various human tissue sources in the management of liver cirrhosis: A systematic review and meta-analysis","volume":"10","author":"Qi","year":"2015","journal-title":"Curr Stem Cell Res Ther"},{"key":"key20200713115203_b20-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.3346\/jkms.2015.30.10.1405","article-title":"Therapeutic effects of mesenchymal stem cells for patients with chronic liver diseases: Systematic review and Meta-analysis","volume":"30","author":"Kim","year":"2015","journal-title":"J Korean Med Sci"},{"key":"key20200713115203_b21-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1097\/MIB.0000000000000543","article-title":"Mesenchymal stem cell therapy for inflammatory bowel disease: A systematic review and Meta-analysis","volume":"21","author":"Dave","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"key20200713115203_b22-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15283\/ijsc17061","article-title":"Mesenchymal stem cell therapy for ischemic heart disease: Systematic review and Meta-analysis","volume":"11","author":"Jeong","year":"2018","journal-title":"Int J Stem Cells"},{"key":"key20200713115203_b23-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"438","DOI":"10.2337\/diacare.5.4.438","article-title":"C-peptide","volume":"5","author":"Hoekstra","year":"1982","journal-title":"Diabetes Care"},{"key":"key20200713115203_b24-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.arcmed.2010.05.007","article-title":"HbA1c for the diagnosis of diabetes mellitus in a developing country. A position article","volume":"41","author":"Gomez-Perez","year":"2010","journal-title":"Arch Med Res"},{"key":"key20200713115203_b25-etm-0-0-6769","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-78665-0_5644","article-title":"Fasting Plasma Glucose","author":"Preedy","year":"2010"},{"key":"key20200713115203_b26-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and Meta-analyses: The PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"key20200713115203_b27-etm-0-0-6769","first-page":"S38","article-title":"Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]","volume":"5","author":"Higgins","year":"2014","journal-title":"naunyn-schmiedebergs archiv f\u00fcr experimentelle pathologie und pharmakologie"},{"key":"key20200713115203_b28-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1056\/NEJMsa1409364","article-title":"Compliance with results reporting at ClinicalTrials.gov","volume":"372","author":"Anderson","year":"2015","journal-title":"N Engl J Med"},{"key":"key20200713115203_b29-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: Is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"key20200713115203_b30-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"key20200713115203_b31-etm-0-0-6769","article-title":"Statistical methods for examining heterogeneity and combining results from several studies in Meta-analysis","volume-title":"Systematic Reviews in Health Care Systematic Reviews in Health Care: Meta-Analysis in Context","author":"Deeks","year":"2008","edition":"2nd"},{"key":"key20200713115203_b32-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/S0895-4356(00)00242-0","article-title":"Publication and related bias in meta-analysis: Power of statistical tests and prevalence in the literature","volume":"53","author":"Sterne","year":"2000","journal-title":"J Clin Epidemiol"},{"key":"key20200713115203_b33-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13287-017-0542-1","article-title":"Immune response after autologous hematopoietic stem cell transplantation in type 1 diabetes mellitus","volume":"8","author":"Ye","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"key20200713115203_b34-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.jcyt.2015.03.608","article-title":"Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow-derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitus","volume":"17","author":"Thakkar","year":"2015","journal-title":"Cytotherapy"},{"key":"key20200713115203_b35-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/bmt.2015.294","article-title":"Immunoablation and autologous hematopoietic stem cell transplantation in the treatment of new-onset type 1 diabetes mellitus: Long-term observations","volume":"51","author":"Snarski","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"key20200713115203_b36-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1016\/j.ebiom.2015.11.003","article-title":"Modulation of autoimmune T-cell memory by stem cell educator therapy: Phase 1\/2 clinical trial","volume":"2","author":"Delgado","year":"2015","journal-title":"EBiomedicine"},{"key":"key20200713115203_b37-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2337\/dc15-0171","article-title":"Umbilical cord mesenchymal stromal cell with autologous bone marrow cell transplantation in established type 1 diabetes: A pilot randomized controlled open-label clinical study to assess safety and impact on insulin secretion","volume":"39","author":"Cai","year":"2016","journal-title":"Diabetes Care"},{"key":"key20200713115203_b38-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/pedi.12072","article-title":"Effect of a single autologous cord blood infusion on beta-cell and immune function in children with new onset type 1 diabetes: A non-randomized, controlled trial","volume":"15","author":"Giannopoulou","year":"2014","journal-title":"Pediatr Diabetes"},{"key":"key20200713115203_b39-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.2337\/db14-0295","article-title":"Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes: A multicenter analysis","volume":"63","author":"D'Addio","year":"2014","journal-title":"Diabetes"},{"key":"key20200713115203_b40-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2337\/db14-0656","article-title":"Preserved \u03b2-cell function in type 1 diabetes by mesenchymal stromal cells","volume":"64","author":"Carlsson","year":"2015","journal-title":"Diabetes"},{"key":"key20200713115203_b41-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1507\/endocrj.EJ12-0343","article-title":"Long term effects of the implantation of Wharton's jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus","volume":"60","author":"Hu","year":"2013","journal-title":"Endoc J"},{"key":"key20200713115203_b42-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.bbmt.2013.04.011","article-title":"Autologous umbilical cord blood infusion followed by oral docosahexaenoic acid and vitamin D supplementation for C-peptide preservation in children with type 1 diabetes","volume":"19","author":"Haller","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"key20200713115203_b43-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1741-7015-10-3","article-title":"Reversal of type 1 diabetes via islet \u03b2 cell regeneration following immune modulation by cord blood-derived multipotent stem cells","volume":"10","author":"Zhao","year":"2012","journal-title":"BMC Med"},{"key":"key20200713115203_b44-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"e31887","DOI":"10.1371\/journal.pone.0031887","article-title":"Acute response of peripheral blood cell to autologous hematopoietic stem cell transplantation in type 1 diabetic patient","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"key":"key20200713115203_b45-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1210\/jc.2011-2188","article-title":"Autologous hematopoietic stem cell transplantation modulates immunocompetent cells and improves \u03b2-cell function in Chinese patients with new onset of type 1 diabetes","volume":"97","author":"Li","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"key20200713115203_b46-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.2337\/dc11-2161","article-title":"Diabetic ketoacidosis at diagnosis influences complete remission after treatment with hematopoietic stem cell transplantation in adolescents with type 1 diabetes","volume":"35","author":"Gu","year":"2012","journal-title":"Diabetes Care"},{"key":"key20200713115203_b47-etm-0-0-6769","first-page":"4363","article-title":"Umbilical cord mesenchymal stem cells transplantation for newly-onset type 1 diabetes","volume":"15","author":"Yu","year":"2011","journal-title":"J Clin Rehabil Tissue Engineering Res"},{"key":"key20200713115203_b48-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.2337\/dc11-1406","article-title":"Autologous umbilical cord blood transfusion in young children with type 1 diabetes fails to preserve C-peptide","volume":"34","author":"Haller","year":"2011","journal-title":"Diabetes Care"},{"key":"key20200713115203_b49-etm-0-0-6769","first-page":"1966","article-title":"Autologous peripheral blood hematopoietic stem cell transplantation in the treatment of type 1 diabetic mellitus: A report of 16 cases","volume":"91","author":"Feng","year":"2011","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"key20200713115203_b50-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"582382","DOI":"10.4061\/2010\/582382","article-title":"Cotransplantation of adipose tissue-derived insulin-secreting mesenchymal stem cells and hematopoietic stem cells: A novel therapy for insulin-dependent diabetes mellitus","volume":"2010","author":"Vanikar","year":"2010","journal-title":"Stem Cells Int"},{"key":"key20200713115203_b51-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/bmt.2010.147","article-title":"Independence of exogenous insulin following immunoablation and stem cell reconstitution in newly diagnosed diabetes type I","volume":"46","author":"Snarski","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"key20200713115203_b52-etm-0-0-6769","first-page":"1023","article-title":"Efficacy and safety of autologous hematopoietic stem cell transplantation in treating type 1 diabetes mellitus","volume":"53","author":"Gu","year":"2010","journal-title":"Chin J Endocrinol Metabol"},{"key":"key20200713115203_b53-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.2337\/dc09-0967","article-title":"Autologous umbilical cord blood transfusion in very young children with type 1 diabetes","volume":"32","author":"Haller","year":"2009","journal-title":"Diabetes Care"},{"key":"key20200713115203_b54-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1001\/jama.2009.470","article-title":"C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus","volume":"301","author":"Couri","year":"2009","journal-title":"JAMA"},{"key":"key20200713115203_b55-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.bbmt.2013.01.001","article-title":"Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model","volume":"19","author":"Wang","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"key20200713115203_b56-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"e64499","DOI":"10.1371\/journal.pone.0064499","article-title":"Electrofusion of mesenchymal stem cells and islet cells for diabetes therapy: A rat model","volume":"8","author":"Yanai","year":"2013","journal-title":"PLoS One"},{"key":"key20200713115203_b57-etm-0-0-6769","doi-asserted-by":"publisher","first-page":"710","DOI":"10.7326\/0003-4819-101-5-710","article-title":"Glycosylated hemoglobin assays in the management and diagnosis of diabetes mellitus. Health and Public Policy Committee, American College of Physicians","volume":"101","year":"1984","journal-title":"Ann Intern Med"},{"key":"key20200713115203_b58-etm-0-0-6769","first-page":"A82","article-title":"Insulin requirements, HbA1c and stimulated C-peptide following autologous umbilical cord blood transfusion in children with T1D","volume":"56","author":"Haller","year":"2007","journal-title":"Diabetes"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T06:52:13Z","timestamp":1594623133000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2018.6769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,19]]},"references-count":58,"URL":"https:\/\/doi.org\/10.3892\/etm.2018.6769","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,19]]}}}